Day One Biopharmaceuticals Inc (DAWN)
17.17
-0.40
(-2.28%)
USD |
NASDAQ |
May 03, 16:00
17.15
-0.02
(-0.12%)
Pre-Market: 20:00
Day One Biopharmaceuticals Cash from Operations (Quarterly): -41.37M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -41.37M |
| September 30, 2023 | -37.06M |
| June 30, 2023 | -42.43M |
| March 31, 2023 | -25.98M |
| December 31, 2022 | -35.31M |
| September 30, 2022 | -23.21M |
| June 30, 2022 | -29.79M |
| March 31, 2022 | -21.56M |
| Date | Value |
|---|---|
| December 31, 2021 | -13.17M |
| September 30, 2021 | -12.22M |
| June 30, 2021 | -13.41M |
| March 31, 2021 | -9.743M |
| December 31, 2020 | -5.938M |
| September 30, 2020 | -3.578M |
| June 30, 2020 | -1.888M |
| March 31, 2020 | -2.085M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-42.43M
Minimum
Jun 2023
-1.888M
Maximum
Jun 2020
-19.92M
Average
-17.48M
Median
Cash from Operations (Quarterly) Benchmarks
| Revolution Medicines Inc | -120.56M |
| Zentalis Pharmaceuticals Inc | -40.60M |
| Perspective Therapeutics Inc | -9.008M |
| Electromed Inc | 3.471M |
| Xtant Medical Holdings Inc | -0.915M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 30.38M |
| Cash from Financing (Quarterly) | 0.597M |
| Free Cash Flow | -150.08M |
| Free Cash Flow Per Share (Quarterly) | -0.4809 |
| Free Cash Flow Yield | -10.96% |